Search research articles
Contact Us
Filters
Showing results (21-30 of 82) with videos related to
Page
of 9
Sort By:
Cancer Research
|
December 18, 2003
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival
Aaron J Berger, Harriet M Kluger, Ning Li, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
December 21, 2005
Melanocyte and keratinocyte carcinogenesis: p53 family protein activities and intersecting mRNA expression profiles
Molly Kulesz-Martin, James Lagowski, Suzanne Fei, et al.
Melanoma Research
|
June 5, 2004
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study
Harriet M Kluger, Kyle DiVito, Aaron J Berger, et al.
BMC Genomics
|
May 17, 2011
Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies
Fabio Parisi, Stephan Ariyan, Deepak Narayan, et al.
The Journal of Biological Chemistry
|
March 3, 2007
XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway
Shawn L Straszewski-Chavez, Irene P Visintin, Natasha Karassina, et al.
Oncotarget
|
May 2, 2019
A novel anti-melanoma SRC-family kinase inhibitor
Ruth Halaban, Antonella Bacchiocchi, Robert Straub, et al.
Proceedings of the American Thoracic Society
|
May 3, 2012
Chitinase-like proteins in lung injury, repair, and metastasis
Chun Geun Lee, Charles S Dela Cruz, Bing Ma, et al.
The Journal of Biological Chemistry
|
January 29, 2002
Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway
Ruth Halaban, Robin S Patton, Elaine Cheng, et al.
Journal of Translational Medicine
|
July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2011
Plasma markers for identifying patients with metastatic melanoma
Harriet M Kluger, Kathleen Hoyt, Antonella Bacchiocchi, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 82) with videos related to
Sort By:
Page
of 9
Cancer Research
|
December 18, 2003
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival
Aaron J Berger, Harriet M Kluger, Ning Li, et al.
The Journal of Investigative Dermatology. Symposium Proceedings
|
December 21, 2005
Melanocyte and keratinocyte carcinogenesis: p53 family protein activities and intersecting mRNA expression profiles
Molly Kulesz-Martin, James Lagowski, Suzanne Fei, et al.
Melanoma Research
|
June 5, 2004
Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study
Harriet M Kluger, Kyle DiVito, Aaron J Berger, et al.
BMC Genomics
|
May 17, 2011
Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies
Fabio Parisi, Stephan Ariyan, Deepak Narayan, et al.
The Journal of Biological Chemistry
|
March 3, 2007
XAF1 mediates tumor necrosis factor-alpha-induced apoptosis and X-linked inhibitor of apoptosis cleavage by acting through the mitochondrial pathway
Shawn L Straszewski-Chavez, Irene P Visintin, Natasha Karassina, et al.
Oncotarget
|
May 2, 2019
A novel anti-melanoma SRC-family kinase inhibitor
Ruth Halaban, Antonella Bacchiocchi, Robert Straub, et al.
Proceedings of the American Thoracic Society
|
May 3, 2012
Chitinase-like proteins in lung injury, repair, and metastasis
Chun Geun Lee, Charles S Dela Cruz, Bing Ma, et al.
The Journal of Biological Chemistry
|
January 29, 2002
Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway
Ruth Halaban, Robin S Patton, Elaine Cheng, et al.
Journal of Translational Medicine
|
July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2011
Plasma markers for identifying patients with metastatic melanoma
Harriet M Kluger, Kathleen Hoyt, Antonella Bacchiocchi, et al.
Page
of 9